Vivanza Biosciences Q1 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
2.37
0.00 (0.00%)
0.00 (0.00%)Volume2.05 L
Updated: Mon 16 Jun, 2025 | 15:54:49
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Vivanza Biosciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2.44 | 0.48 | -44.85% | 2.44 | N/A |
| Selling/ General/ Admin Expenses Total | 0.15 | 0.15 | 49.61% | 0.15 | N/A |
| Depreciation/ Amortization | 0.00 | 0.00 | -70.00% | 0.00 | N/A |
| Other Operating Expenses Total | 0.10 | 0.11 | 5.44% | 0.10 | N/A |
| Total Operating Expense | 2.08 | 1.44 | -54.38% | 2.08 | N/A |
| Operating Income | 0.36 | -0.96 | 0.00% | 0.36 | N/A |
| Net Income Before Taxes | 0.27 | -0.99 | 0.00% | 0.27 | N/A |
| Net Income | 0.27 | -1.00 | 0.00% | 0.27 | N/A |
| Diluted Normalized EPS | 0.07 | -0.25 | 0.00% | 0.07 | N/A |